Page last updated: 2024-11-07

penicillamine and Cardiomyopathies, Primary

penicillamine has been researched along with Cardiomyopathies, Primary in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"A case of severe diffuse systemic sclerosis with cardiomegaly and cardiac failure is described."1.26Treatment of scleroderma heart by D-penicillamine. ( Muers, M; Stokes, W, 1976)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loke, KE1
Messina, EJ1
Mital, S1
Hintze, TH1
Muers, M1
Stokes, W1

Other Studies

2 other studies available for penicillamine and Cardiomyopathies, Primary

ArticleYear
Impaired nitric oxide modulation of myocardial oxygen consumption in genetically cardiomyopathic hamsters.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:12

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomyopat

2000
Treatment of scleroderma heart by D-penicillamine.
    British heart journal, 1976, Volume: 38, Issue:8

    Topics: Adult; Cardiomegaly; Cardiomyopathies; Exercise Test; Female; Heart Failure; Humans; Penicillamine;

1976